+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Virbac Group (VIRP) - Financial and Strategic SWOT Analysis Review

  • PDF Icon

    SWOT Analysis

  • 41 Pages
  • May 2023
  • GlobalData
  • Virbac Group
  • ID: 3277062
Virbac Group (VIRP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by the publisher to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

  • Business description - A detailed description of the company’s operations and business divisions.
  • Corporate strategy - Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history - Progression of key events associated with the company.
  • Major products and services - A list of major products, services and brands of the company.
  • Key competitors - A list of key competitors to the company.
  • Key employees - A list of the key executives of the company.
  • Executive biographies - A brief summary of the executives’ employment history.
  • Key operational heads - A list of personnel heading key departments/functions.
  • Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
  • Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.


Virbac Group (Virbac) is an animal health company, which focuses on the development and production of vaccines and medicines for domestic animals and livestock. It manufactures pet medications such as vaccines, antibiotics, parasiticides, dental products, nutrition, diagnosis, anti-inflammatory drugs and dermatological products. Virbac’s products include ear cleanser for dogs and cats; food supplement for cattle; tablets for the prevention of canine heartworm disease and treatment of roundworms and hookworms; general anesthetics, among others. The company operates manufacturing, research and development, and subsidiaries in Europe, North America, Latin America, Asia-Pacific, Africa and the Middle East. Virbac is headquartered in Carros Cedex, France.

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company

Table of Contents

Section 1 - About the Company
  • Virbac Group - Key Facts
  • Virbac Group - Key Employees
  • Virbac Group - Key Employee Biographies
  • Virbac Group - Major Products and Services
  • Virbac Group - History
  • Virbac Group - Company Statement
  • Virbac Group - Locations And Subsidiaries
  • Head Office
  • Other Locations & Subsidiaries
Section 2 - Company Analysis
  • Company Overview
  • Virbac Group - Business Description
  • Geographical Segment: Africa & Middle East
  • Performance
  • Geographical Segment: Asia
  • Performance
  • Geographical Segment: Europe (excluding France)
  • Performance
  • Geographical Segment: France
  • Performance
  • Geographical Segment: Latin America
  • Performance
  • Geographical Segment: North America
  • Performance
  • Geographical Segment: Pacific
  • Performance
  • R&D Overview
  • Virbac Group - Corporate Strategy
  • Virbac Group - SWOT Analysis
  • SWOT Analysis - Overview
  • Virbac Group - Strengths
  • Virbac Group - Weaknesses
  • Virbac Group - Opportunities
  • Virbac Group - Threats
  • Virbac Group - Key Competitors
Section 3 - Company Financial Ratios
  • Financial Ratios - Capital Market Ratios
  • Financial Ratios - Annual Ratios
  • Performance Chart
  • Financial Performance
  • Financial Ratios - Interim Ratios
  • Financial Ratios - Ratio Charts
Section 4 - Company’s Lifesciences Financial Deals and Alliances
  • Virbac Group, Pharmaceuticals & Healthcare, Deals By Year, 2017 to YTD 2023
  • Virbac Group, Pharmaceuticals & Healthcare, Deals By Type, 2017 to YTD 2023
  • Virbac Group, Recent Deals Summary
Section 5 - Appendix
  • Methodology
  • Ratio Definitions
  • About the Publisher
  • Contact the Publisher
  • Disclaimer
List of Tables
  • Virbac Group, Key Facts
  • Virbac Group, Key Employees
  • Virbac Group, Key Employee Biographies
  • Virbac Group, Major Products and Services
  • Virbac Group, History
  • Virbac Group, Subsidiaries
  • Virbac Group, Key Competitors
  • Virbac Group, Ratios based on current share price
  • Virbac Group, Annual Ratios
  • Virbac Group, Interim Ratios
  • Virbac Group, Pharmaceuticals & Healthcare, Deals By Year, 2017 to YTD 2023
  • Virbac Group, Pharmaceuticals & Healthcare, Deals By Type, 2017 to YTD 2023
  • Virbac Group, Recent Deals Summary
  • Currency Codes
  • Capital Market Ratios
  • Equity Ratios
  • Profitability Ratios
  • Cost Ratios
  • Liquidity Ratios
  • Leverage Ratios
  • Efficiency Ratios
List of Figures
  • Virbac Group, Performance Chart (2018 - 2022)
  • Virbac Group, Ratio Charts
  • Virbac Group, Pharmaceuticals & Healthcare, Deals By Year, 2017 to YTD 2023
  • Virbac Group, Pharmaceuticals & Healthcare, Deals by Type, 2017 to YTD 2023



Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Elanco Animal Health Inc
  • Vetoquinol SA
  • Dechra Veterinary Products Limited
  • Idexx Laboratories Inc
  • Ceva Sante Animale SA
  • Provet SA
  • Heska Corp
  • Vetoquinol SA
  • Provet SA
  • Heska Corp
  • Dechra Veterinary Products Limited
  • Elanco Animal Health Inc
  • Idexx Laboratories Inc
  • Ceva Sante Animale SA